Phathom Pharmaceuticals (PHAT)
(Delayed Data from NSDQ)
$12.21 USD
+0.39 (3.30%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $12.30 +0.09 (0.74%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Phathom Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PHAT 12.21 +0.39(3.30%)
Will PHAT be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for PHAT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHAT
Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here's Why
Wall Street Analysts See a 66.13% Upside in Phathom Pharmaceuticals (PHAT): Can the Stock Really Move This High?
PHAT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Phathom Pharmaceuticals (PHAT) Could Surge 87.21%: Read This Before Placing a Bet
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates
MannKind (MNKD) Reports Break-Even Earnings for Q2
Other News for PHAT
NR7 appears for PHAT after 3.3% move
Is PHAT signaling a buying opportunity? 20 Day Moving Average Support shows up after declining 3.82%
Is PHAT primed for upward momentum? Crossed Above 20 Day Moving Average shows up after advancing 4.42%
PHAT forms Pocket Pivot on September 30
12 Health Care Stocks Moving In Wednesday's After-Market Session